Enzon Pharmaceuticals, Inc. (ENZN)
Market Open
25 Jul, 20:00
OTC PINK OTC PINK Primary $
0. 08
-0.01
-11.11%
$
6.02M Market Cap
- P/E Ratio
0.48% Div Yield
448,000 Volume
- Eps
$ 0.09
Previous Close Day Range
0.07 0.1
Year Range
0.06 0.24
Want to track ENZN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
ENZN trading today lower at $0.08, a decrease of 11.11% from yesterday's close, completing a monthly decrease of -38.46% or $0.05. Over the past 12 months, ENZN stock lost -60%.
ENZN is not paying dividends to its shareholders.
The last earnings report, released on May 08, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).
ENZN Chart
Enzon Pharmaceuticals, Inc. Dividends
ENZN is not paying dividends to its shareholders.
Enzon Pharmaceuticals, Inc. Earnings
| 8 May 2025 Date | | - Cons. EPS | - EPS |
| 18 Mar 2025 Date | | - Cons. EPS | - EPS |
| 7 Nov 2024 Date | | - Cons. EPS | - EPS |
| 8 Aug 2024 Date | | - Cons. EPS | - EPS |
| 7 Aug 2024 Date | | - Cons. EPS | - EPS |
ENZN is not paying dividends to its shareholders.
| 8 May 2025 Date | | - Cons. EPS | - EPS |
| 18 Mar 2025 Date | | - Cons. EPS | - EPS |
| 7 Nov 2024 Date | | - Cons. EPS | - EPS |
| 8 Aug 2024 Date | | - Cons. EPS | - EPS |
| 7 Aug 2024 Date | | - Cons. EPS | - EPS |
Enzon Pharmaceuticals, Inc. (ENZN) FAQ
What is the stock price today?
The current price is $0.08.
On which exchange is it traded?
Enzon Pharmaceuticals, Inc. is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is ENZN.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.48%.
What is its market cap?
As of today, the market cap is 6.02M.
Has Enzon Pharmaceuticals, Inc. ever had a stock split?
No, there has never been a stock split.
Enzon Pharmaceuticals, Inc. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Richard L. Feinstein CPA CEO | OTC PINK Exchange | 293904108 Cusip |
| US Country | - Employees | - Last Dividend | 29 Sep 2017 Last Split | - IPO Date |
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
Contact Information
Address: 20 Commerce Drive
Phone: 732 980 4500
Website: https://www.enzon.com
2025 © Marketlog. All Rights Reserved.
